A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects
Clinical trial NCT06158737 · COMPLETED
Trial details
- NCT number
- NCT06158737
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2024-06-23
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.